Stanniocalcin-1 : A Novel Molecular Blood and Bone Marrow Marker for Human Breast Cancer 1

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Lymphatic mapping and sentinel lymphadenectomy for breast cancer.

  2004cited by this paper
• Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors.

  2001cited by this paper
• The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence

  2001cited by this paper
• Molecular strategy for detecting metastatic cancers with use of multiple tumor-specific MAGE-A genes.

  2001cited by this paper
• Molecular determinants of occult metastatic tumor cells in bone marrow.

  2001influential reference
• Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.

  2001cited by this paper
• Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy.

  2001influential reference
• Transcriptional response to hypoxia in human tumors.

  2001cited by this paper
• Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics.

  2001cited by this paper
• Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patients.

  2001cited by this paper
• Bone marrow micrometastases detected by RT-PCR for mammaglobin can be an alternative prognostic factor of breast cancer

  2001cited by this paper
• Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.

  2000cited by this paper
• Molecular detection of metastatic pancreatic carcinoma cells using a multimarker reverse transcriptase–polymerase chain reaction assay

  2000cited by this paper
• Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction and immunocytochemical techniques.

  2000cited by this paper
• Chromosome 8p alterations in sporadic andBRCA2 999del5 linked breast cancer

  2000cited by this paper
• Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

  2000cited by this paper
• Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA.

  1999cited by this paper
• Expression of MUC-1 epitopes on normal bone marrow: implications for the detection of micrometastatic tumor cells.

  1999cited by this paper
• Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer.

  1999cited by this paper
• Analysis of potential markers for detection of submicroscopic lymph node metastases in breast cancer

  1999cited by this paper
• Detection and clinical importance of micrometastatic disease.

  1999cited by this paper
• Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study.

  1999cited by this paper
• Comparison of immunocytochemistry, reverse transcriptase polymerase chain reaction, and nucleic acid sequence–based amplification for the detection of circulating breast cancer cells

  1999cited by this paper
• Localization of a tumor suppressor gene associated with the progression of human breast carcinoma within a 1‐cm interval of 8p22–p23.1

  1999cited by this paper
• Human stanniocalcin (STC): genomic structure, chromosomal localization, and the presence of CAG trinucleotide repeats.

  1998cited by this paper
• [Prognostic factors in breast cancer].

  1998cited by this paper
• Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.

  1998cited by this paper
• Stanniocalcin: a novel protein regulating calcium and phosphate transport across mammalian intestine.

  1998cited by this paper
• Detection of tyrosinase mRNA in melanoma by reverse transcription-PCR and electrochemiluminescence.

  1998cited by this paper
• Stanniocalcin in the seawater salmon: structure, function, and regulation.

  1998cited by this paper
• Genetic analysis of 53 lymph node‐negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors

  1998cited by this paper
• Molecular cloning and characterization of stanniocalcin-related protein

  1998cited by this paper
• Comparative analysis of mammalian stanniocalcin genes.

  1998cited by this paper
• Allelic loss of chromosomal arm 8p in breast cancer progression.

  1998cited by this paper
• Pattern of dissemination and survival following isolated locoregional recurrence of breast cancer

  1997cited by this paper
• Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma.

  1997cited by this paper
• Human Stanniocalcin Inhibits Renal Phosphate Excretion in the Rat

  1997cited by this paper
• Human stanniocalcin: a possible hormonal regulator of mineral metabolism.

  1996cited by this paper
• Detection of metastatic breast cancer by β‐hCG polymerase chain reaction

  1996cited by this paper
• A novel human cDNA highly homologous to the fish hormone stanniocalcin.

  1995cited by this paper
• Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay.

  1995cited by this paper
• Karnofsky Memorial Lecture. Natural history of small breast cancers.

  1994cited by this paper
• Purification, characterization, and bioassay of teleocalcin, a glycoprotein from salmon corpuscles of Stannius.

  1986cited by this paper
• Diseases of the Breast

  1888cited by this paper

• Expression of Stanniocalcin-1 as a Predictor of Recurrence in Breast Cancer Patients

  2022cites this paper
• Development and validation of novel risk prediction models of breast cancer based on stanniocalcin‐1 level

  2022cites this paper
• Molecular and Clinical Significance of Stanniocalcin-1 Expression in Breast Cancer Through Promotion of Homologous Recombination-Mediated DNA Damage Repair

  2021cites this paper
• Research progress of STC2 in breast cancer

  2021cites this paper
• Expression, function and clinical application of stanniocalcin‐1 in cancer

  2020cites this paper
• Role of stanniocalcin-1 in breast cancer

  2019influential citation
• Intravitreal Stanniocalcin-1 Enhances New Blood Vessel Growth in a Rat Model of Laser-Induced Choroidal Neovascularization

  2018cites this paper
• CAPG enhances breast cancer metastasis by competing with PRMT5 to modulate STC-1 transcription

  2018cites this paper
• Stanniocalcin Expression as a Predictor of Late Breast Cancer Recurrence

  2018cites this paper
• Effects of STC1 overexpression on tumorigenicity and metabolism of hepatocellular carcinoma

  2017cites this paper
• Transcriptional regulation of 5′-flanking regions of stanniocalcin genes by estrogen receptor and estrogen receptor-related receptor

  2016influential citation
• Stanniocalcin-1 relates to tumor recurrence and unfavorable prognosis of urothelial bladder cancer

  2016cites this paper
• Stanniocalcin-1 Controls Ion Regulation Functions of Ion-transporting Epithelium Other than Calcium Balance

  2015cites this paper
• Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma

  2015cites this paper
• Magnetic bead-based separation of sperm from buccal epithelial cells using a monoclonal antibody against MOSPD3

  2014cites this paper
• STC1 expression is associated with tumor growth and metastasis in breast cancer

  2014cites this paper
• Clinical significance of stanniocalcin expression in tissue and serum of gastric cancer patients.

  2014cites this paper
• Stanniocalcin-1 promotes metastasis in a human breast cancer cell line through activation of PI3K

  2014cites this paper
• The role of Stanniocalcin-1 in vascular cell function

  2013cites this paper
• Expression of stanniocalcin-1 in culprit coronary plaques of patients with acute myocardial infarction or stable angina

  2013cites this paper
• Expression of Stanniocalcin 1 as a Potential Biomarker of Gastric Cancer

  2012cites this paper
• Clinical significance of stanniocalcin-1 detected in peripheral blood and bone marrow of esophageal squamous cell carcinoma patients

  2012cites this paper
• Human stanniocalcin-1 interacts with nuclear and cytoplasmic proteins and acts as a SUMO E3 ligase.

  2011cites this paper
• Stanniocalcin-1 Regulates Re-Epithelialization in Human Keratinocytes

  2011cites this paper
• Stanniocalcin-1 promotes tumor angiogenesis through up-regulation of VEGF in gastric cancer cells

  2011cites this paper
• Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinoma

  2011cites this paper
• The diagnostic value of circulating stanniocalcin‐1 mRNA in non‐small cell lung cancer

  2011cites this paper
• SALL4 is essential for cancer cell proliferation and is overexpressed at early clinical stages in breast cancer.

  2011cites this paper
• Clinical significance of STC1 gene expression in patients with colorectal cancer.

  2011cites this paper
• Clinical Significance of STC 1 Gene Expression in Patients with Colorectal Cancer

  2011cites this paper
• Identification and characterization of the hypoxia-responsive element in human stanniocalcin-1 gene

  2010cites this paper
• Stanniocalcin 1 and ovarian tumorigenesis.

  2010cites this paper
• Stanniocalcin-1 detection of peripheral blood in patients with colorectal cancer

  2010cites this paper
• Enhanced Mammary Progesterone Receptor-A Isoform Activity in the Promotion of Mammary Tumor Progression by Dietary Soy in Rats

  2010cites this paper
• Low-resolution structural studies of human Stanniocalcin-1

  2009cites this paper
• Regulation of microRNA expression by HMGA1 proteins

  2009cites this paper
• Wnt2 acts as an angiogenic growth factor for non-sinusoidal endothelial cells and inhibits expression of stanniocalcin-1

  2009cites this paper
• Tumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancer.

  2009cites this paper
• Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas.

  2009cites this paper
• Pathophysiology of tumor-associated macrophages.

  2008cites this paper
• Detection of Circulating Tumor Cells in Early-Stage Breast Cancer Metastasis to Axillary Lymph Nodes

  2007cites this paper
• Detection of CirculatingTumor Cells in Early-Stage Breast Cancer Metastasis toAxillary Lymph Nodes

  2007cites this paper
• Induction of stanniocalcin-1 expression in apoptotic human nasopharyngeal cancer cells by p53.

  2007cites this paper
• Isolated tumor cells in bone marrow of early-stage breast cancer patients.

  2006cites this paper
• CHAPTER 211 – Fish Peptides

  2006cites this paper
• Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function

  2006cites this paper
• Stanniocalcin: no longer just a fish tale.

  2005cites this paper
• Hypoxia-inducible factor-1-mediated activation of stanniocalcin-1 in human cancer cells.

  2005cites this paper
• Tumor-associated macrophages: the double-edged sword in cancer progression.

  2005cites this paper
• Co-localization of stanniocalcin-1 ligand and receptor in human breast carcinomas.

  2004cites this paper
• Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis

  2004cites this paper
• Evidence for stanniocalcin and a related receptor in annelids.

  2004cites this paper
• Stanniocalcin-1 as a novel marker to detect minimal residual disease of human leukemia.

  2004cites this paper